The Trips Agreement and Public Health: Rethinking Compulsory Licensing as a Tool for Pharmaceutical Patent Flexibility

Author(s)	Dr. KUMARA N H
Country	India
Abstract	This paper re-examines compulsory licensing as a crucial tool for achieving pharmaceutical patent flexibility, particularly in the context of the TRIPS Agreement and Public Health. Compulsory licensing, which permits a government to authorize the production of a patented drug without the patent holder's consent, is often viewed as a last-resort measure. However, this study argues that it represents a vital and legitimate policy tool that can be strategically employed to address drug accessibility crises.
Keywords	Public Health, Compulsory Licensing, TRIPS Agreement, Pharmaceutical Patents, Drug Accessibility, Doha Declaration, Generic Drugs, WTO, Innovation.
Field	Sociology > Administration / Law / Management
Published In	Volume 16, Issue 4, October-December 2025
Published On	2025-11-03
DOI	https://doi.org/10.71097/IJSAT.v16.i4.9218
Short DOI	https://doi.org/g99qkx

About IJSAT Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us	Message on WhatsApp	+91-9687-182-185	editor@ijsat.org

International Journal on Science and Technology